June 2011 - Volume 21 - Issue 6 - Contributor Index

Alphabetical Search
I
Q
U
W
X
Y

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Author:
Altman, Russ B.
Author:
Belanger, Alain

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene.

Ekström, Lena; Schulze, Jenny J.; Guillemette, Chantal; More

Pharmacogenetics and Genomics. 21(6):325-332, June 2011.

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Author:
Borgiani, Paola

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Author:
Broly, Franck

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study

Price, Elvin Tyrone; Pacanowski, Michael A.; Martin, Michael A.; More

Pharmacogenetics and Genomics. 21(6):333-340, June 2011.

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Author:
Ekström, Lena

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene.

Ekström, Lena; Schulze, Jenny J.; Guillemette, Chantal; More

Pharmacogenetics and Genomics. 21(6):325-332, June 2011.

Author:
Falconi, Mattia

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Author:
Forte, Vittorio

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Author:
Garat, Anne

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene.

Ekström, Lena; Schulze, Jenny J.; Guillemette, Chantal; More

Pharmacogenetics and Genomics. 21(6):325-332, June 2011.

Author:
Jiang, Ruhong

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study

Price, Elvin Tyrone; Pacanowski, Michael A.; Martin, Michael A.; More

Pharmacogenetics and Genomics. 21(6):333-340, June 2011.

Author:
Klein, Teri E.
Author:
Leal, Vera L.G.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?

Bourgine, Joanna; Garat, Anne; Allorge, Delphine; More

Pharmacogenetics and Genomics. 21(6):313-324, June 2011.

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study

Price, Elvin Tyrone; Pacanowski, Michael A.; Martin, Michael A.; More

Pharmacogenetics and Genomics. 21(6):333-340, June 2011.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Author:
Mi, Huaiyu

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Author:
Ott, Christian

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study

Price, Elvin Tyrone; Pacanowski, Michael A.; Martin, Michael A.; More

Pharmacogenetics and Genomics. 21(6):333-340, June 2011.

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Ciccacci, Cinzia; Falconi, Mattia; Paolillo, Nicoletta; More

Pharmacogenetics and Genomics. 21(6):344-346, June 2011.

Author:
Pepine, Carl J.

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study

Price, Elvin Tyrone; Pacanowski, Michael A.; Martin, Michael A.; More

Pharmacogenetics and Genomics. 21(6):333-340, June 2011.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study

Price, Elvin Tyrone; Pacanowski, Michael A.; Martin, Michael A.; More

Pharmacogenetics and Genomics. 21(6):333-340, June 2011.

Author:
Rane, Anders

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene.

Ekström, Lena; Schulze, Jenny J.; Guillemette, Chantal; More

Pharmacogenetics and Genomics. 21(6):325-332, June 2011.

Author:
Ring, Huijun Z.

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene.

Ekström, Lena; Schulze, Jenny J.; Guillemette, Chantal; More

Pharmacogenetics and Genomics. 21(6):325-332, June 2011.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Author:
Thomas, Paul D.

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer

Vargens, Daniela D.; Neves, Ronaldo R.S.; Bulzico, Daniel A.; More

Pharmacogenetics and Genomics. 21(6):341-343, June 2011.

Author:
Zineh, Issam

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study

Price, Elvin Tyrone; Pacanowski, Michael A.; Martin, Michael A.; More

Pharmacogenetics and Genomics. 21(6):333-340, June 2011.

Show: